0001457716-15-000052.txt : 20151210 0001457716-15-000052.hdr.sgml : 20151210 20151210113850 ACCESSION NUMBER: 0001457716-15-000052 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20151210 DATE AS OF CHANGE: 20151210 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: PROTECT PHARMACEUTICAL Corp CENTRAL INDEX KEY: 0001493526 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 271877179 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-88587 FILM NUMBER: 151280228 BUSINESS ADDRESS: STREET 1: 2681 EAST PARLEYS WAY STREET 2: SUITE 204 CITY: SALT LAKE CITY STATE: UT ZIP: 84109 BUSINESS PHONE: 8013223401 MAIL ADDRESS: STREET 1: 2681 EAST PARLEYS WAY STREET 2: SUITE 204 CITY: SALT LAKE CITY STATE: UT ZIP: 84109 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: KCG AMERICAS LLC CENTRAL INDEX KEY: 0001457716 IRS NUMBER: 264219373 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A BUSINESS ADDRESS: STREET 1: 545 WASHINGTON BLVD. CITY: JERSEY CITY STATE: NJ ZIP: 07310 BUSINESS PHONE: 201-356-1390 MAIL ADDRESS: STREET 1: 545 WASHINGTON BLVD. CITY: JERSEY CITY STATE: NJ ZIP: 07310 FORMER COMPANY: FORMER CONFORMED NAME: KNIGHT CAPITAL AMERICAS LLC DATE OF NAME CHANGE: 20120822 FORMER COMPANY: FORMER CONFORMED NAME: KNIGHT EXECUTION & CLEARING SERVICES LLC DATE OF NAME CHANGE: 20120711 FORMER COMPANY: FORMER CONFORMED NAME: KNIGHT CAPITAL AMERICAS LLC DATE OF NAME CHANGE: 20120710 SC 13G/A 1 kcg2015033113ga.htm PRTT 13 G/A 11-30-15 SC 13G

 
 
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
____________________
Schedule 13G/A

Under the Securities Exchange Act of 1934
(Amendment 1)

____________________

 Protect Pharmaceutical Corp.
(Name of Issuer)
 
____________________

Common Stock
(Title of Class of Securities)
74364W203
(CUSIP Number)
November 30, 2015
(Date of Event Which Requires Filing of this Statement)

 ____________________

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
x Rule 13d-1(b)
¨ Rule 13d-1(c)
¨ Rule 13d-1(d)
 
*
 
The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.


The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 
 










SCHEDULE 13G/A
 
CUSIP No.
74364W203
1.
 
Name of reporting person
I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (entities only)

KCG Americas LLC 26-4219373
2.
 
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a)   ¨         (b)   ¨
 
3.
 
SEC Use only
4.
 
Citizenship or place of organization
   
     Delaware
Number of shares beneficially owned by each reporting person with
 
5.
 
Sole voting power
16,297
 
6.
 
Shared voting power
 
    Not applicable
 
7.
 
Sole dispositive power
16,297
 
8.
 
Shared dispositive power
 
    Not applicable
9.
 
Aggregate amount beneficially owned by each reporting person
16,297
10.
 
Check box if the aggregate amount in Row (9) excludes certain shares* ¨
 
11.
 
Percent of class represented by amount in Row 9


 
 
1.47%
based on outstanding shares reported on the issuer's 10-Q filed with the SEC for the period ended September 30, 2015.
12.
 
Type of reporting person*
 
    BD



 
 
 
 
 
 
 
 
 
 
 
ITEM 1
(a).
 
Name of Issuer
 
 
 
 
 
 
 
 
 
 
 
 
 
Protect Pharmaceutical Corp.
 
 
 
 
 
 
 
 
 
 
ITEM 1
(b).
 
Address of Issuer’s Principal Executive Offices
 
 
 
 
 
 
 
 
 
 
 
 
 
2681 Parleys Way, Suite 204, Salt Lake City, UT 84109
 
 
 
 
 
 
 
 
 
 
ITEM 2
(a).
 
Names of Persons Filing
 
 
 
 
 
 
 
 
 
 
 
 
 
KCG Americas LLC
 
 
 
 
 
 
 
 
 
 
ITEM 2
(b).
 
Address of principal business office
 
 
 
 
 
 
 
 
 
 
 
 
 
545 Washington Blvd.,
Jersey City, NJ 07310
 
 
 
 
 
 
 
 
 
 
ITEM 2
(c).
 
Citizenship
 
 
 
 
 
 
 
 
 
 
 
 
 
Delaware
 
 
 
 
 
 
 
 
 
 
ITEM 2
(d).
 
Title of Class of Securities
 
 
 
 
 
 
 
 
 
 
 
 
 
Common Stock
 
 
 
 
 
 
 
 
 
 
ITEM 2
(e).
 
CUSIP Number
 
 
 
 
 
 
 
 
 
 
 
 
 
74364W203
 
 
 
 
 
 
 
ITEM 3.
           If this statement is filed pursuant to Rules 13d-1(b), or 13(d)-2(b), check whether the person filing it is a:
 
 
 
 
 
 
 
 
(a)
 
x
Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o).




























 
 
 
 
 
 
 
 
ITEM 4.
Ownership
 
 
 
 
 
 
 
 
 
(a)
Amount beneficially owned
 
 
 
 
 
 
 
 
 
 
 
16,297
 
 
 
 
 
 
 
 
 
(b)
Percent of class
 
 
 
 
 
 
 
 
 
 
 
1.47 %
 
 
 
 
 
 
 
 
 
(c)
Number of shares as to which such person has:
 
 
 
 
 
 
 
 
 
 
 
 
(i)
sole power to vote or to direct the vote
 
 
 
 
 
 
 
 
 
 
 
 
 
16,297
 
 
 
 
 
 
 
 
 
 
 
 
(ii)
shared power to vote or to direct the vote
 
 
 
 
 
 
 
 
 
 
 
 
 
Not applicable
 
 
 
 
 
 
 
 
 
 
 
 
(iii)
sole power to dispose or to direct the disposition of
 
 
 
 
 
 
 
 
 
 
 
 
 
16,297
 
 
 
 
 
 
 
 
 
 
 
 
(iv)
shared power to dispose or to direct the disposition of
 
 
 
 
 
 
 
 
 
 
 
 
 
Not applicable
 
 
 
 
 
 
 
ITEM 5.
Ownership of Five Percent or Less of a Class
 
 
 
 
 
Not applicable
 
 
 
 
 
 
ITEM 6.
Ownership of More than Five Percent on Behalf of Another Person
 
 
 
 
 
 
 
 
Not applicable
 
 
 
 
 
 
ITEM 7.
Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company
 
 
Not applicable.
 
 
 
 
ITEM 8.
Identification and Classification of Members of the Group
 
 
 
 
 
 
 
 
Not applicable.
 
 
 
 
 
 
 
 
ITEM 9.
Notice of Dissolution of Group
 
 
 
 
 
 
 
 
Not applicable.
 
 
 
 
 
 
 
 
ITEM 10.
Certification
 
 
 
 
 
 
 
 
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.
 
 
 
 
 
 
 
 
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
 
 
 
 


Date: December 10, 2015
 
 
 
 
KCG Americas LLC
 
 
By:
 
/s/ Matthew Levine
 
 
Matthew Levine
 
 
Chief Compliance Officer